Key result
Redo-pulmonary valve replacement using a valved conduit successfully treated prosthetic pulmonary valve endocarditis without recurrence over a 2-year follow-up.
Case Report (n=1)
No
Redo-pulmonary valve replacement using a valved conduit in the Rastelli fashion may be a viable surgical alternative for treating prosthetic pulmonary valve endocarditis while minimizing the risk of pulmonary arterial wall injury.
May represent a viable surgical option in prosthetic pulmonary valve endocarditis; leaves open need for larger studies before practice change.
A 51-year-old male was admitted to the hospital with complaints of fever and hemoptysis. After evaluation of the fever focus, he was diagnosed with pulmonary valve infective endocarditis. Thus pulmonary valve replacement and antibiotics therapy were performed and discharged. He was brought to the emergency unit presenting with a high fever (>39℃) and general weakness 6 months after the initial operation. The echocardiography revealed prosthetic pulmonary valve endocarditis. Therefore, redo-pulmonary valve replacement using valved conduit was performed in the Rastelli fashion because of the risk of pulmonary arterial wall injury and recurrent endocarditis from the remnant inflammatory tissue. We report here on the successful surgical treatment of prosthetic pulmonary valve endocarditis with an alternative surgical method.
No takes yet. Share an insight, caveat, or question.
Jung et al. (2013) conducted a case report in Prosthetic pulmonary valve endocarditis (n=1). Redo-pulmonary valve replacement using a valved conduit was evaluated on Clinical outcome (survival and recurrence). Redo-pulmonary valve replacement using a valved conduit successfully treated prosthetic pulmonary valve endocarditis without recurrence over a 2-year follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: